Corning Life Sciences and Emerging Growth Businesses — Depreciation decreased by 10.3% to $26.00M in Q1 2026 compared to the prior quarter.
An increase often correlates with recent capital investments, while a decrease may signal aging infrastructure or reduced asset utilization.
This metric represents the systematic allocation of the cost of tangible assets used within the Life Sciences and Emergi...
Comparable to depreciation and amortization charges in capital-intensive manufacturing segments.
glw_segment_life_sciences_and_emerging_growth_businesses_depreciation| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | $29.00M | $26.00M |
| QoQ Change | — | -10.3% |
| YoY Change | — | -10.3% |